NEW YORK – Quanterix said Tuesday that it has submitted a 510(k) premarket notification to the US Food and Drug Administration for its Lucent AD Complete multi-analyte algorithmic blood test for ...
NEW YORK – After expanding sales and improving reimbursement in 2025, autoimmune diagnostic company Exagen is preparing to spend 2026 developing new tests, including one for lupus nephritis that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results